本页面由Tiger Trade Technology Pte. Ltd.提供服务

Werewolf Therapeutics, Inc.

0.7802
+0.01021.32%
成交量:17.89万
成交额:13.96万
市值:3,787.11万
市盈率:-0.48
高:0.8003
开:0.7958
低:0.7624
收:0.7700
52周最高:2.38
52周最低:0.5301
股本:4,854.02万
流通股本:3,500.26万
量比:0.89
换手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):-1.6177
每股收益(LYR):-1.6273
净资产收益率:-122.43%
总资产收益率:-40.75%
市净率:1.28
市盈率(LYR):-0.48

数据加载中...

2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]